NATIONAL GUARD HEALTH AFFAIRS
πΈπ¦Saudi Arabia
- Country
- πΈπ¦Saudi Arabia
- Ownership
- -
- Established
- 1983-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
14
Active:0
Completed:2
Trial Phases
3 Phases
Phase 2:5
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)β’ Click on a phase to view related trials
Phase 2
5 (71.4%)Phase 3
1 (14.3%)Phase 4
1 (14.3%)A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer.
Phase 2
- Conditions
- Colon Cancer
- Interventions
- Drug: investigator choice re-challenge with anti EGFR Rx
- First Posted Date
- 2021-03-01
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 60
- Registration Number
- NCT04775862
- Locations
- πΈπ¦
Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia
Clinical Utilization of Newly Approved Oncology Medications
- Conditions
- Cancer
- First Posted Date
- 2016-05-26
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 100
- Registration Number
- NCT02783885
- Locations
- πΈπ¦
King Abdul Aziz Medical City for National Guard Health Affairs, Riyadh, Saudi Arabia
πΈπ¦King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia
Risk Assessment Tool in Saudi Arabia
- Conditions
- Breast Cancer
- First Posted Date
- 2016-05-24
- Last Posted Date
- 2016-05-24
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 2000
- Registration Number
- NCT02781116
- Locations
- πΈπ¦
King Abdul Aziz Medical City for National Guard Health Affairs, Riyadh, Saudi Arabia
Quality of the End of Life Care
Completed
- Conditions
- Cancer
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 180
- Registration Number
- NCT02775825
- Locations
- πΈπ¦
King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia
HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- National Guard Health Affairs
- Target Recruit Count
- 15
- Registration Number
- NCT02776202
- Locations
- πΈπ¦
King Abdul Aziz Medical City for National Guard, Riyadh, Saudi Arabia
- Prev
- 1
- 2
- 3
- Next
News
No news found